Why hydroxyethyl starch solutions should not be banned from the operating room

Anaesthesiology Intensive Therapy

Volumn 46, Issue 5, 2014, Pages 336-341

  De Hert, Stefan ^a   De Baerdemaeker, Luc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Hydroxyethyl starches; Perioperative period; Safety

Indexed keywords

HETASTARCH; INFUSION FLUID; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

ALLERGIC REACTION; BLOOD VOLUME; CLINICAL PRACTICE; CRITICALLY ILL PATIENT; CRYSTALLOID; DEHYDRATION; EUROPEAN; EXTRACELLULAR FLUID; FLUID BALANCE; FLUID RESUSCITATION; FLUID SHIFT; FLUID THERAPY; HEMODYNAMICS; HUMAN; INJURY; INTRAVASCULAR SPACE; MOLECULAR WEIGHT; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; RENAL REPLACEMENT THERAPY; REVIEW; SURGERY; THERMOREGULATION; TOTAL BODY WATER; URINE VOLUME; ADVERSE EFFECTS; DRUG EFFECTS; ELECTROLYTE BALANCE; OPERATING ROOM; PEROPERATIVE CARE; PROCEDURES;

FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INTRAOPERATIVE CARE; OPERATING ROOMS; PLASMA SUBSTITUTES; WATER-ELECTROLYTE BALANCE;

EID: 84916885340     PISSN: 16425758     EISSN: 17312531     Source Type: Journal    
DOI: 10.5603/AIT.2014.0057     Document Type: Review

References (51)

1. Weiser TG, Regenbogen SE, Thompson KD et al.: An estimation of the global volume of surgery: a modeling strategy based on available data. Lancet 2008; 372: 139-144.
2. Pearse RM, Moreno RP, Bauer P et al.: Mortality after surgery in Europe: a 7 day cohort study. Lancet 2012; 380: 1059-1065.
3. Kehlet H: Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997; 78: 606-617.
4. Lassen K, Soop M, Nygren J et al.: Consensus review of optimal perioperative care in colorectal surgery: enhanced recovery after surgery (ERAS) group recommendations. Arch Surg 2009; 144: 961-969.
5. Jacob M, Chappell D, Hofmann-Kiefer K, Conzen P, Peter K, Rehm M: Determinants of insensible fluid loss. Perspiration, protein shift and endothelial glycocalyx. Anaesthesist 2007; 56: 747-764.
6. Chappel D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M: A rational approach to perioperative fluid management. Anesthesiology 2008; 109: 723-740.
7. Jacob M, Chappell D: Reappraising Starling: the physiology of the microcirculation. Curr Opin Crit Care 2013; 19: 282-289.
8. Hamilton MA, Cecconi M, Rhodes A: A systematic review and meta-analysis on the use of preemptive haemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 2011; 112: 1392-1402.
9. Powell-Tuck JG, Lobo DN, Allison SP et al.: British consenus guidelines on intravenous fluid therapy for adult surgical patients. 2011. http://www.bapen.org.uk/pdfs/bapen-pubs/giftasup.pdf
10. Reinhart K, Perner A, Sprung CL et al.: Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012; 38: 368-383.
11. Zacharowski K, Van Aken H, Marx G et al.; Comments on Reinhart: Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012; 38: 1556-1557.
12. Meybohm P, Van Aken H, De Gasperi A et al.: Re-evaluating currently available data and suggestions for planning randomized controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement. Crit Care 2013; 17: R166.
13. Coriat P, Guidet B, De Hert S, Kochs E, Kozek S, Van Aken H: Counter statement to open letter to the executive director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 2014; 113: 194-195.
14. http://www.ema.europa.eu/docs/en-GB/document-library/Referrals-document/Solutions-for-infusion-containing-hydroxyethyl-starch/Recommendation-provided-by-Pharmacovigilance-Risk-Assessment-Committee/WC500144448.pdf
15. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Hydroxyethyl-starchcontaining-medicines/human-referral-prac-000029.jsp&mid=WC0b01ac05805c516f
16. Jacob M, Chappell D, Hofmann-Kiefer K et al.: The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humans. Crit Care 2012; 16: R86.
17. Rehm M, Zahler S, Lotsch M et al.: Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004; 100: 1211-1223.
18. Hammersborg SM, Farstad M, Haugen O, Kvalheim V, Onarheim H, Husby P: Time course variations of haemodynamics, plasma volume and microvascular fluid exchange following surface cooling. An experimental approach to accidental hypothermia. Resuscitation 2005; 65: 211-219.
19. Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR: Postoperative fluid overload: not a benign problem. Crit Care Med 1990; 18: 728-733.
20. Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L: Improved survival in ARDS patients associated with a reductionin pulmonary capillary wedge pressure. Chest 1990; 97: 1176-1180.
21. Schuller D, Mitchell JP, Calandrino FS, Schuster DP: Fluid balance during pulmonary edema: is fluid gain a marker or a cause of poor outcome? Chest 1991; 100: 1068-1075.
22. Bundgaard-Nielsen M, Secher NH, Kehlet H: Liberal vs restrictive perioperative fluid therapy - a critical assessment of the evidence. Acta Anaesthesiol Scand 2009; 53: 843-851.
23. Giglio MT, Marucci M, Testini M, Brienza N: Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth 2009; 103: 637-646.
24. Corcoran T, Rhodes JEJ, Clarke S, Myles PS, Ho KM: Perioperative fluid management strategies in major surgery: a stratified meta-analysis. Anesth Analg 2012; 114: 640-651.
25. Guerin L, Monnet X, Teboul JL: Monitoring volume and fluid responsiveness: from static to dynamic indicators. Best Pract Res Clin Anaesthesiol 2013; 27: 177-185.
26. De Hert SG: Assessment of fluid responsiveness: insights in a "gray zone". Anesthesiology 2011; 115: 229-230.
27. De Hert S: Noninvasive haemodynamic monitoring devices: new tools or just another toy? Anesthesiology 2014; 120: 1065-1066.
28. Campbell IT, Baxter JN, Tweedie IE, Taylor GT, Keens SJ: IV fluids during surgery. Br J Anaesth 1990; 65: 726-729.
29. Lamke LO, Nilsson GE, Reithner HL: Water loss by evaporation from the abdominal cavity during surgery. Acta Chir Scand 1977; 143: 279-284.
30. Jacob M, Chappell D, Conzen P, Finsterer U, Rehm M: Blood volume is normal after preoperative overnight fasting. Acta Anaesthesiol Scand 2008; 52: 522-529.
31. Rehm M, Haller M, Orth V et al.: Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetasatrch solutions in patients before radical hysterectomy. Anesthesiology 2001; 85: 849-856.
32. Jacob M, Chappell D, Rehm M: Clinical update: perioperative fluid management. Lancet 2007; 369: 1984-1986.
33. th ed., Philadelphia, Churchill Livingstone 2005: 1763-1798.
34. Salmon JB, Mythen MG: Pharmacology and physiology of colloids. Blood Rev 1993; 7: 114-120.
35. Vercueil A, Grocott MPW, Mythen MG: Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective haemodynamic stability in critically ill patients. Transfus Med Rev 2005; 19: 93-109.
36. Van der Linden PJ, De Hert SG, Deraedt D et al.: Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005; 101: 629-634.
37. Gondos T, Marjanek Z, Ulakcsai Z et al.: Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol 2010; 27: 794-800.
38. Laxenaire MC, Moneret-Vautrin DA et al.: Anesthetics responsible for anaphylactic shock. A French multicenter study. Ann Fr Anesth Reanim 1990; 9: 501-506.
39. Laxenaire MC, Mertes PM: Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87: 549-558.
40. Finfer S, Liu B, Taylor C et al.: Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010; 14: R185.
41. Rivers E, Nguyen B, Havstad S et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
42. Chappell D, Jacob M: Hydroxyethyl starch - the importance of being earnest. Scand J Trauma Resusc Emerg Med 2013; 21: 61.
43. Brunkhorst FM, Engel C, Bloos F et al.: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139.
44. Dellinger RP, Levy MM, Rhodes A et al: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2013; 41: 580-637.
45. Perner A, Haase N, Guttormsen AB et al.: Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-134.
46. Myburgh JA, Finfer S, Bellomo R et al.: Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-1911.
47. James MF, Michell WL, Joubert IA, Navsaria PH, Gillespie RS: Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107: 693-702.
48. Guidet B, Martinet O, Boulain T et al.: Assessment of haemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012; 16: R94.
49. Annane D, Siami S, Jaber S et al.: Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shoch. The CRISTAL randomized trial. JAMA 2013; 310: 1809-1817.
50. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A: Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118: 387-394.
51. Van der Linden P, James M, Mythen M, Weiskopf RB: Safety of modern starches during surgery. Anesth Analg 2013; 166: 35-48.